Fatal Acute Motor Axonal Neuropathy Induced by Nivolumab: A Case Report and Literature Review
- 5 August 2019
- journal article
- review article
- Published by Elsevier BV in Clinical Genitourinary Cancer
- Vol. 17 (6), e1104-e1107
- https://doi.org/10.1016/j.clgc.2019.07.020
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Neuromuscular Complications of Programmed Cell Death-1 (PD-1) InhibitorsCurrent Neurology and Neuroscience Reports, 2018
- Guillain–Barré Syndrome Triggered by Immune Checkpoint Inhibitors: A Case Report and Literature ReviewJournal of Clinical Neuromuscular Disease, 2017
- Immune mediated neuropathy following checkpoint immunotherapyJournal of Clinical Neuroscience, 2017
- A Case of Nivolumab-Induced Severe Mononeuropathy Multiplex and RhabdomyolysisCase Reports in Medicine, 2017
- Acute demyelinating polyneuropathy induced by nivolumabJournal of Neurology, Neurosurgery & Psychiatry, 2017
- PD-1 Antibody-induced Guillain-Barré Syndrome in a Patient with Metastatic MelanomaActa Dermato-Venereologica, 2017
- Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain–Barré syndrome: a case reportJapanese Journal of Clinical Oncology, 2016
- A case of fatal Guillain–Barre syndrome from anti-PD1 monoclonal antibody useZeitschrift für Krebsforschung und Klinische Onkologie, 2016
- Nivolumab in Previously Untreated Melanoma withoutBRAFMutationThe New England Journal of Medicine, 2015
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerThe New England Journal of Medicine, 2012